Literature DB >> 8158136

Acute and persistent suppression of preproenkephalin mRNA expression in the striatum following developmental hypoxic-ischemic injury.

R E Burke1, S O Franklin, C E Inturrisi.   

Abstract

The striatum is vulnerable to hypoxic-ischemic injury during development. In a rodent model of perinatal hypoxia-ischemia, it has been shown that striatal neurons are not uniformly vulnerable. Cholinergic neurons and NADPH-diaphorase-positive neurons are relatively spared. However, it is unknown what classes of striatal neurons are relatively sensitive. One of the major classes of striatal neurons uses enkephalin as a neurotransmitter. We have studied the effect of early hypoxic-ischemic injury on this class of neurons using a quantitative solution hybridization assay for preproenkephalin mRNA in conjunction with in situ hybridization. Hypoxia-ischemia results in an early (up to 24 h) decrease in striatal preproenkephalin mRNA, which is shown by in situ hybridization to occur mainly in the dorsal portion of the striatum. By 14 days, whole striatal preproenkephalin mRNA and total enkephalin-containing peptide levels are normal. However, at 14 days, in situ hybridization reveals that regions of complete preproenkephalin mRNA-positive neuron loss remain in the dorsal region. Normal whole striatal levels are due to an up-regulation of preproenkephalin mRNA expression in the ventrolateral region of the injured striatum. Given the important role that the enkephalin-containing striatal efferent projection plays in regulating motor function, its relative loss may be important in the chronic disturbances of motor control observed in brain injury due to developmental hypoxic-ischemic injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158136     DOI: 10.1046/j.1471-4159.1994.62051878.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Anatomical basis of glial cell line-derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat.

Authors:  Tinmarla Frances Oo; Vincent Ries; Jinwhan Cho; Nikolai Kholodilov; Robert E Burke
Journal:  J Comp Neurol       Date:  2005-03-28       Impact factor: 3.215

2.  Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia.

Authors:  Garnik Akopian; Cynthia Crawford; M Flint Beal; Maurand Cappelletti; Michael W Jakowec; Giselle M Petzinger; Ling Zheng; Stacey L Gheorghe; Carmela M Reichel; Robert Chow; John P Walsh
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

3.  CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism.

Authors:  Robert M Silva; Vincent Ries; Tinmarla Frances Oo; Olga Yarygina; Vernice Jackson-Lewis; Elizabeth J Ryu; Phoebe D Lu; Stefan J Marciniak; David Ron; Serge Przedborski; Nikolai Kholodilov; Lloyd A Greene; Robert E Burke
Journal:  J Neurochem       Date:  2005-08-31       Impact factor: 5.372

4.  Neurotrophic effects of serum- and glucocorticoid-inducible kinase on adult murine mesencephalic dopamine neurons.

Authors:  Xiqun Chen; Patricia Tagliaferro; Tatyana Kareva; Olga Yarygina; Nikolai Kholodilov; Robert E Burke
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

5.  An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease.

Authors:  Patricia Tagliaferro; Tatyana Kareva; Tinmarla F Oo; Olga Yarygina; Nikolai Kholodilov; Robert E Burke
Journal:  Neurobiol Dis       Date:  2015-07-17       Impact factor: 5.996

6.  Brain-derived neurotrophic factor regulates early postnatal developmental cell death of dopamine neurons of the substantia nigra in vivo.

Authors:  Tinmarla F Oo; Deanna M Marchionini; Olga Yarygina; Paul D O'Leary; Richard A Hughes; Nikolai Kholodilov; Robert E Burke
Journal:  Mol Cell Neurosci       Date:  2009-05-03       Impact factor: 4.314

7.  Previous Injury and Chronic Pain are Associated with Side of Onset in Parkinson's Disease.

Authors:  Izel Tekin; Angeliki Vgontzas; Mechelle M Lewis; Saira Kothari; Lan Kong; Yue Lu; Kent E Vrana; Xuemei Huang
Journal:  J Neurol Neurobiol       Date:  2015-07-25

Review 8.  Dystonia and chorea in acquired systemic disorders.

Authors:  J L Janavs; M J Aminoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.